Medscape2h
Intra-arterial Thrombolysis Fails to Improve Stroke Outcomes
Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...
The Cardiology Advisor20h
Developing Dementia After Stroke: What Is the Risk for Stroke Survivors?
Among stroke survivors, the risk of developing dementia after stroke is significantly high, highlighting the need for targeted prevention strategies.
Bristol-Myers Squibb Company (BMY) Presents at Leerink Partners 2025 Global Healthcare Conference (Transcript)
Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...
Infectious Disease Advisor20h
Patients With COVID-19 Have Worse Recovery Outcomes Following Ischemic Stroke
A study has found that patients with ischemic stroke and COVID-19, compared with patients without COVID-19, experience worse recovery outcomes.
The Cardiology Advisor18h
TNKase Approved for Treatment of Acute Ischemic Stroke
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.